Fortelyzin for acute ischaemic stroke treatment: an open, prospective, non-interventional, observational study FORPI registry

The presented data confirm that intravenous thrombolysis with Fortelyzin is safe and effective in routine clinical practice when used within 4.5 h of AIS symptoms onset. These findings should encourage the wider usage of thrombolytic therapy for suitable patients.

Authors

Institutions

Publication Details

Journal
S S Korsakov Journal of Neurology and Psychiatry
Published
2025-12-30
DOI
https://doi.org/10.17116/jnevro202512512143
Citations
2
Primary Topic
Acute Ischemic Stroke Management
Type
article
Field-Weighted Citation Impact
2.71
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Fortelyzin for acute ischaemic stroke treatment: an open, prospective, non-interventional, observational study FORPI registry

E.L. Kuzmin, P.N. Nikov, N. I. Uskova, A.Yu. Lebedeva et al.
2 citations
S S Korsakov Journal of Neurology and Psychiatry
Acute Ischemic Stroke Management
2.71
article

Fortelyzin for acute ischaemic stroke treatment: an open, prospective, non-interventional, observational study FORPI registry

E.L. Kuzmin, P.N. Nikov, N. I. Uskova, A.Yu. Lebedeva, M.B. Tekeev, N.V. Komissarova, Karpova Ea, P.G. Philippov, E.N. Shishkina, Yu. A. Romashova, M. K. Guseva, V.G. Maltsev, Zh. Yu. Chefranova, M.M. Shabalina, V. A. Saskin, A. A. Karasev, E I Gusev, S.A. Fedyanin, R.M. Mamina Mamina, A. Yu. Schegolev, L. A. Batukaeva, A.V. Shatunova, A.K. Volkova, L.L. Korsunskaya, M.Yu. Martynov, E.B. Yarovaya, С. В. Иванов, V. M. Alifirova, S. E. Chuprina, M.S. Cherepyansky, O.V. Tikhomirova, A.N. Chirkov, N.V. Khalo, A.A. Kulesh, N.A. Marskaya, A.G. Azarova, D.R. Khasanova, V.N. Nesterova, Kh.D. Mongush, G.S. Brutyan, O.E. Ivlev, A.N. Bukaeva, S.N. Gasambekova, I.V. Kladova, Yu.A. Lykov, N.V. Andreyko, D.S. Khan, A.A. Bort, A.A. Timofeev, N.A. Shamalov, O.V. Androphagina, A.G. Soplenkova, S.S. Markin, M.A. Kholopov, I.V. Korobeynikov, E.A. Golubeva, A.M. Semenov, S.V. Tabakman, V.A. Evdokimova, S.A. Vakazheva, A.E. Birukov, N.N. Strambovskaya, T.V. Kharitonova, F.K. Dzugaeva, S.I. Kurnosov, S.F. Sharina, V.V. Abramceva, V.I. Maximov, K.V. Khoroshavina, S.V. Farenbrukh, E.V. Slasten, V.V. Ivanova, I.A. Voznuk, Yu.V. Batueva, M.P. Semenov, A.R. Rakhmatullin, A.I. Sazhnev, S.A. Lisin, M.Kh. Balaeva, N.N. Kirukhina, V.A. Kutsenko, N.P. Zinovieva, E.I. Daynikova, I.A. Gaponenko, N.N. Maslova, I.V. Teryaeva, M.V. Sutormin, M.D. Bogatyreva, N.V. Zhukovskaya, V.A. Ternovskaya, E.S. Ulimbasheva, L.V. Timchenko, A.A. Shamin, A.E. Terentyeva, D.L. Stepushenkova, I.M. Karamova, A.A. Mnev
article en
2 citations

Abstract

The presented data confirm that intravenous thrombolysis with Fortelyzin is safe and effective in routine clinical practice when used within 4.5 h of AIS symptoms onset. These findings should encourage the wider usage of thrombolytic therapy for suitable patients.

S S Korsakov Journal of Neurology and PsychiatryVol. 125(12)
Chechen State University (RU), Belgorod National Research University (RU), Kazan State Medical University (RU), Siberian State Medical University (RU), Lomonosov Moscow State University (RU), Kalmyk State University (RU), Caucasus University (GE), First Pavlov State Medical University of St. Petersburg (RU), Central Vermont Medical Center (US), Pirogov Russian National Research Medical University (RU), Perm State Medical Academy (RU), Stavropol Regional Clinical Oncology Center (RU), Nizhny Novgorod Regional Clinical Hospital named after Semashko (RU), Kurgan State Agricultural Academy by T S Maltsev (RU), Leningrad Regional Cancer Center (RU), Tver State Medical University (RU), Academy of Sciences of the Republic of Sakha (RU), Clinical Hospital No. 8 (RU), Dagestan State Medical University (RU), Smolensk State Medical University (RU), City Hospital (GB), Kabardino-Balkarian Scientific Center (RU), Irkutsk Regional Clinical Hospital (RU), Ivanovo State Medical Academy (RU), Budgetary Healthcare Institution of Omsk Region Regional Clinical Hospital (RU), Saint-Petersburg I. I. Dzhanelidze Research Institute of Emergency Medicine (RU), City Clinical Hospital (RU), Zhengzhou Central Hospital (CN), City Clinical Hospital No. 2 (RU), St. Petersburg State Medical Academy "City Polyclinic №44" (RU), City Clinical Hospital No 31 (RU), Kursk Regional Clinical Oncology Center (RU), Central Clinical Hospital (PL), Regional Clinical Research (US), Zabaikalsky State Humanitarian and Pedagogical University (RU), Karachay-Cherkess State Pedagogical University (RU), Regional Children's Clinical Hospital No. 1 (RU), Regional Children's Hospital No1 (RU), Magadan Research Institute of Agriculture (RU), SuperGen (United States) (US), Moscow State University (TJ), Samara Regional Clinical Hospital named after V.D. Seredavina (RU), Institute of Biomedical Chemistry (RU), Shin Koga Hospital (JP), Orenburg Regional Clinical Hospital №2 (RU), Amita Health St. Mary's Hospital (US), The First Republican Clinical Hospital of the Ministry of Health of the Udmurt Republic (RU), Ministry of Health (RW), Nikiforov Russian Center of Emergency and Radiation Medicine (RU), Republican Clinical Hospital named after G.G. Kuvatova (RU)
Good health and well-being
Openalex Percentile: Top 8%
Acute Ischemic Stroke Management
2.71
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.